Determining if a new cosmetic product, pharmaceutical ingredient, or chemical substance is harmful to humans is a key prerequisite for product safety and consumer protection. Traditionally, skin sensitization testing relied […]
In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for qualitative and quantitative skin sensitizing potency assessment, filling in data […]
This presentation will introduce GARDskin Dose-Response assay, a novel approach for the assessment of relative skin sensitizing potency on a continuous scale. Results demonstrate that induction of toxicity pathways in […]
11th World Congress on Alternatives and Animal Use in the Life Sciences 23 August - 2 September 2021 | Virtual Congress Posters open for viewing: Aug 10 - Sep […]
User cases on hazard and potency assessment Given the huge interest in our previous webinar on GARD user cases, we are pleased to offer you a new opportunity to hear […]
Eurotox 2021 Virtual Congress 27 September - 1 October 🌎Industry symposium hosted by SenzaGen Sep 29, 17.30 - 18.30 Filling data gaps in skin sensitization testing: in vitro hazard […]
The international innovation fair for cosmetic and perfume industry October 13-14 | Carrousel du Louvre, Paris | Booth: S4 Meet SenzaGen and partners PKDerm, GenEvolutioN, WatchFrog and CEHTRA at Cosmetic 360, […]
In this webinar, the speakers will discuss the uses of in vitro assays as a part of the risk assessment and biological evaluation for the following endpoints: cytotoxicity, skin irritation and skin sensitization. Key topics […]
Filling data gaps in skin sensitization testing: In vitro hazard and potency assessment using GARD In case you missed SenzaGen's industry symposium at this year's Eurotox Virtual Congress, here is a […]
An Overview of Established Methods and New Approach Methodologies (NAMs) In this joint webinar, we will present an overview of established methods and New Approach Methodologies (NAMs) used in the […]
